Our previous data showed that, when compared with F group, LC lesions presented stronger inflammatory profile with higher number of lesions, longer duration and required longer treatment duration, as well as more in situ CD4+ cells, neutrophils, and more intense NOS2 expression [11]. The gene discussed is NOS2; the disease is laryngotracheoesophageal cleft.